Crocker Gary L's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Aug 14, 2023
- Accession no.
- 0000950170-23-042384
- Filed
- Aug 14, 2023
- Trade date
- Aug 10-11, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $49.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crocker Gary LCIK 0001094201 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $12.52 | +$25,040 | 133,105 | Indirect | |
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $12.43 | +$24,860 | 133,105 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.